Not Theory. Not Hype. Real insights from the deep experts shaping precision medicine.
The Institute@Precision draws on the expertise of Precision Medicine Group – an ecosystem of experts advancing treatments and access across the biopharma development lifecycle.
With doctors, scientists, former regulators, and former access & reimbursement decision-makers on our team, the Institute@Precision moves beyond hype to deliver insights from leading voices in precision medicine.
Our leadership
Our expertise is grounded in our experience.
25+
years conducting clinical trials
450+
launches and label expansions
2500+
clinical trial and lab projects
145+
oncology launches
250+
market clearances for Dx and CDx
150+
scientific and medical experts with advanced degrees

Meet our Experts

Precision for Medicine
Precision AQ
Ross Maclean, MD
Executive Vice President, Partner - HEOR and Access Strategy

Precision for Medicine
Precision AQ
Eve Jamali
Senior Vice President, Managing Director – Global Pricing and Access Strategy & Analytics

Precision for Medicine
Precision AQ
Maureen Hennessey, PhD
Senior Vice President, Director of Value Transformation

Precision for Medicine
Precision AQ
Angelica Norrell, PharmD
Senior Director, Access Experience Team - Market Access
Interested in a specific topic?
Collaborate with the Institute@Precision on our upcoming research.
This is just the beginning.
Explore our complete collection of insights
























